Skip to content

Evaluation of Daily Disposable Lenses With Multi-Purpose Solution (MPS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00733291
Enrollment
64
Registered
2008-08-13
Start date
2008-01-31
Completion date
2008-02-29
Last updated
2011-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Keywords

Daily disposable contact lenses, Multi-purpose disinfecting solutions

Brief summary

The purpose of this study is to evaluate daily disposable lenses inserted out of the blister package versus daily disposable lenses inserted after a pre-soak in Multi-purpose solution FID 107027.

Detailed description

Corneal staining and subjective responses for ocular redness and comfort will be compared.

Interventions

Commercially marketed, single vision, soft contact lens for daily disposable wear

Commercially marketed, single vision, soft contact lens for daily disposable wear

DEVICEFID 107027 solution

Commercially marketed solution for contact lens disinfection

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older. * Visual acuity correctable to 20/30 (Snellen) or better in each eye at distance with contact lenses. * Successfully wearing hydrogel or silicone hydrogel contact lenses on a daily wear basis for at least two weeks prior to study. * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* History of hypersensitivity to any components of the multi-purpose solution. * Evidence or history of ocular conditions as prescribed in protocol. * One functional eye or a monofit lens * Any slit-lamp finding score equal to 1 at Visit 1 of each study period. * Significant corneal staining at visit 1 of each study period as prescribed in protocol. * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Average Corneal Staining AreaAfter 2 hours of wearPercentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.
Total Corneal Staining TypeAfter 2 hours of wearTotal corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (\>/= 1mm). The five regions were summed.

Secondary

MeasureTime frameDescription
Ocular ComfortAfter 2 hours of wearOcular comfort was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, Right now my eyes feel... with one of the following responses: 1-very comfortable; 2-comfortable; 3-neither comfortable nor uncomfortable; 4-uncomfortable; 5-very uncomfortable.
Ocular RednessAfter two hours of wearOcular redness was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, Right now my eyes look... with one of the following responses: 1-very white; 2-white; 3-neither white nor red; 4-red; 5-very red.

Countries

United States

Participant flow

Recruitment details

64 subjects currently wearing hydrogel or silicone hydrogel lenses on a daily wear schedule for at least two weeks were enrolled between 1/7/08 and 2/1/08 by 4 US optometry sites

Pre-assignment details

18 hours of no contact lens wear (glasses only) served as the wash out before Period 1. This reporting group includes all enrolled and dispensed participants as treated.

Participants by arm

ArmCount
Nelfilcon A Contact Lens
Commercially marketed, single vision, soft contact lens for daily disposable wear
29
Etafilcon A Contact Lens
Commercially marketed, single vision, soft contact lens for daily disposable wear
34
Total63

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Washout Period, 3 Days (+/-1 Day)Failed inc criteria Second Intervention1000

Baseline characteristics

CharacteristicNelfilcon A Contact LensEtafilcon A Contact LensTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
2 Participants0 Participants2 Participants
Age, Categorical
Between 18 and 65 years
27 Participants34 Participants61 Participants
Age Continuous37.59 years
STANDARD_DEVIATION 13.9
38.56 years
STANDARD_DEVIATION 12.42
38.11 years
STANDARD_DEVIATION 13.02
Sex: Female, Male
Female
16 Participants25 Participants41 Participants
Sex: Female, Male
Male
13 Participants9 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 300 / 300 / 340 / 34
serious
Total, serious adverse events
0 / 300 / 300 / 340 / 34

Outcome results

Primary

Average Corneal Staining Area

Percentage corneal staining was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Percentage corneal staining area was recorded in increments of ten, and the percentages of the five regions were averaged together.

Time frame: After 2 hours of wear

Population: This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A / FID 107027Average Corneal Staining Area0.27 Percentage area of corneaStandard Deviation 0.39
Nelfilcon A / no SoakAverage Corneal Staining Area0.08 Percentage area of corneaStandard Deviation 0.13
Etafilcon A / FID 107027Average Corneal Staining Area0.34 Percentage area of corneaStandard Deviation 0.63
Etafilcon A / no SoakAverage Corneal Staining Area0.18 Percentage area of corneaStandard Deviation 0.25
Primary

Total Corneal Staining Type

Total corneal staining type was assessed by the investigator for each of 5 regions of the cornea, i.e., four quadrants plus central. The investigator instilled fluorescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and a yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0-none; 1-micropunctate; 2-macropunctate; 3-coalesced macropunctate; 4-patch (\>/= 1mm). The five regions were summed.

Time frame: After 2 hours of wear

Population: This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A / FID 107027Total Corneal Staining Type1.59 Units on a scaleStandard Deviation 1.43
Nelfilcon A / no SoakTotal Corneal Staining Type0.79 Units on a scaleStandard Deviation 1.18
Etafilcon A / FID 107027Total Corneal Staining Type1.32 Units on a scaleStandard Deviation 1.8
Etafilcon A / no SoakTotal Corneal Staining Type1.00 Units on a scaleStandard Deviation 1.23
Secondary

Ocular Comfort

Ocular comfort was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, Right now my eyes feel... with one of the following responses: 1-very comfortable; 2-comfortable; 3-neither comfortable nor uncomfortable; 4-uncomfortable; 5-very uncomfortable.

Time frame: After 2 hours of wear

Population: This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A / FID 107027Ocular Comfort1.86 Units on a scaleStandard Deviation 0.92
Nelfilcon A / no SoakOcular Comfort1.83 Units on a scaleStandard Deviation 0.8
Etafilcon A / FID 107027Ocular Comfort1.65 Units on a scaleStandard Deviation 0.69
Etafilcon A / no SoakOcular Comfort1.88 Units on a scaleStandard Deviation 0.88
Secondary

Ocular Redness

Ocular redness was recorded by the participant on a questionnaire using a 5-point scale. Participant completed the sentence, Right now my eyes look... with one of the following responses: 1-very white; 2-white; 3-neither white nor red; 4-red; 5-very red.

Time frame: After two hours of wear

Population: This reporting group is based on the number of subjects in the evaluable population for the indicated lens as treated.

ArmMeasureValue (MEAN)Dispersion
Nelfilcon A / FID 107027Ocular Redness2.07 Units on a scaleStandard Deviation 0.46
Nelfilcon A / no SoakOcular Redness2.10 Units on a scaleStandard Deviation 0.72
Etafilcon A / FID 107027Ocular Redness2.18 Units on a scaleStandard Deviation 0.76
Etafilcon A / no SoakOcular Redness2.06 Units on a scaleStandard Deviation 0.69

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026